سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

BCG therapy for bladder cancer

Publish Year: 1397
Type: Conference paper
Language: English
View: 646
این Paper فقط به صورت چکیده توسط دبیرخانه ارسال شده است و فایل کامل قابل دریافت نیست. برای یافتن Papers دارای فایل کامل، از بخش [جستجوی مقالات فارسی] اقدام فرمایید.

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

Export:

Link to this Paper:

Document National Code:

MBMED05_023

Index date: 22 December 2018

BCG therapy for bladder cancer abstract

Background: BCG therapy is used as a treatment in bladder cancer. Methods: Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. Results and Conclution: He was treated successfully with antitubercular therapy and prednisolone.

BCG therapy for bladder cancer Keywords:

BCG therapy for bladder cancer authors

Mohsen Ayati

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Reza Nowroozi

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Afshin Mortazavi

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Solmaz Ohadian Moghadam

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran